Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?

Mult Scler. 2018 Sep;24(10):1387-1388. doi: 10.1177/1352458517749895. Epub 2018 Jan 8.

Authors

Insa Schiffmann¹, Jutta Scheiderbauer², Karin Riemann-Lorenz¹, Christoph Heesen^{1

3}

Affiliations

¹ 1 Institut für Neuroimmunologie und Multiple Sklerose, Germany.
² 2 Trierer Aktionsgruppe (TAG) Multiple Sklerose, Germany.
³ 3 Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Neurologie, MS Tagesklinik, Germany.

PMID: 29308975
DOI: 10.1177/1352458517749895

No abstract available

Publication types

Comment

MeSH terms

Atrophy
Brain
Cladribine
Humans
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting*
Tablets

Substances

Tablets
Cladribine